Prostate Cancer Screening market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Prostate Cancer Screening market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Segment by Application
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott Laboratories
Almac
Bayer
Beckman Coulter
Biom?Rieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics